Skip to main content
52°
Mostly Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
League of Women Voters SRI
League of Women Voters WS
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Terns Pharmaceuticals, Inc.
< Previous
1
2
Next >
Terns Pharmaceuticals Presents Late-Breaking Data from Phase 2a DUET Trial of THR-β Agonist TERN-501 in NASH at AASLD The Liver Meeting® 2023
November 13, 2023
From
Terns Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
TERN
Terns Pharmaceuticals to Participate in Upcoming November Investor Conferences
November 09, 2023
From
Terns Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
TERN
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
November 03, 2023
From
Terns Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
TERN
Terns Pharmaceuticals Announces First Participant Dosed in Phase 1 Clinical Trial of TERN-601 Oral GLP-1 Receptor Agonist for Treatment of Obesity
November 02, 2023
From
Terns Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
TERN
Terns Pharmaceuticals to Participate in Upcoming Investor Conferences
October 19, 2023
From
Terns Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
TERN
Terns Pharmaceuticals Announces Global Phase 1 Clinical Trial Design of TERN-701 for the Treatment of Chronic Myeloid Leukemia
October 16, 2023
From
Terns Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
TERN
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
October 03, 2023
From
Terns Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
TERN
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
September 06, 2023
From
Terns Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
TERN
Terns Pharmaceuticals to Participate in Upcoming September Investor Conferences
September 05, 2023
From
Terns Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
TERN
Terns Pharmaceuticals Reports Second Quarter 2023 Financial Results and Corporate Updates
August 08, 2023
From
Terns Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
TERN
Terns Achieves Primary Endpoint and All Secondary Endpoints in Phase 2a DUET Trial of THR-β Agonist TERN-501 in NASH
August 08, 2023
From
Terns Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
TERN
Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)
August 03, 2023
From
Terns Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
TERN
Terns Pharmaceuticals Announces Leadership Transition
August 03, 2023
From
Terns Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
TERN
Terns Pharmaceuticals to Host Virtual Key Opinion Leader Event to Discuss TERN-701 and Advances in the Treatment Landscape for Chronic Myeloid Leukemia
July 18, 2023
From
Terns Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
TERN
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
July 05, 2023
From
Terns Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
TERN
Terns Pharmaceuticals Highlights New Preclinical Data for TERN-601 Program in Obesity at the ADA’s 83rd Annual Scientific Session and Upcoming Events
June 26, 2023
From
Terns Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
TERN
Terns Pharmaceuticals to Present at Goldman Sachs 44th Annual Global Healthcare Conference
June 06, 2023
From
Terns Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
TERN
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
June 02, 2023
From
Terns Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
TERN
Terns Pharmaceuticals Announces Publication of TERN-701 Trial-in-Progress Abstract for the 2023 ASCO Annual Meeting
May 25, 2023
From
Terns Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
TERN
Terns Pharmaceuticals to Present at Upcoming Investor Conferences
May 24, 2023
From
Terns Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
TERN
Terns Pharmaceuticals to Highlight New Preclinical Data for TERN-601 Program in Obesity at the American Diabetes Association’s 83rd Annual Scientific Sessions
May 22, 2023
From
Terns Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
TERN
Terns Pharmaceuticals Reports First Quarter 2023 Financial Results and Corporate Updates
May 15, 2023
From
Terns Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
TERN
Terns Pharmaceuticals to Participate in the JMP Securities 2023 Life Sciences Conference
May 09, 2023
From
Terns Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
TERN
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
May 03, 2023
From
Terns Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
TERN
Terns Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Updates
March 27, 2023
From
Terns Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
TERN
Terns Pharmaceuticals Appoints Emil Kuriakose, M.D., as Chief Medical Officer of Terns Oncology
March 27, 2023
From
Terns Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
TERN
Terns Pharmaceuticals Provides Program Updates and Announces Participation at Upcoming March Investor Conferences
March 02, 2023
From
Terns Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
TERN
Terns Pharmaceuticals to Participate in Guggenheim Healthcare Talks 2023 Oncology Conference
February 02, 2023
From
Terns Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
TERN
Terns Pharmaceuticals to Present at B. Riley Securities’ 3rd Annual Oncology Conference
January 12, 2023
From
Terns Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
TERN
Terns Pharmaceuticals to Highlight 2023 Priorities and Clinical Milestones at the 41st Annual J.P. Morgan Healthcare Conference
January 05, 2023
From
Terns Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
TERN
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.